Trial Review

The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12609000135213
Ethics application status
Approved
Date submitted
10/02/2009
Date registered
2/03/2009
Date last updated
2/12/2015
Type of registration
Prospectively registered

Titles & IDs
Public title
Shyness 6: Internet based education for social phobia with telephone reminders or online forum support. A randomized controlled study
Scientific title
A randomized controlled trial of Internet based education for social phobia comparing telephone reminders vs. access to an online discussion forum on severity of symptoms of social phobia.
Secondary ID [1] 288051 0
Nil Known
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Social phobia (an anxiety disorder) 4298 0
Condition category
Condition code
Mental Health 4529 4529 0 0
Anxiety

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Participants will be randomly assigned to one of two groups: 1) Internet based education for social phobia with automatic email, short messaging service (sms) reminders, and weekly telephone reminders from an administrative assistant, or; 2) Internet based education for social phobia with automatic email and sms reminders, and online discussion forum support from a clinical psychologist. All participants will meet Diagnostic and Statistical Manual of Mental Disorders 4th Edition (DSM-IV) criteria for social phobia. All participants will complete 6 lessons of Internet based education about management of symptoms of social phobia. One lesson will be completed every 7 to 10 days. Each lesson will take about 15 minutes to complete. Participants will also have access to summaries of each lesson, and will read anonymous stories about other people with social phobia, taking a further 20 minutes per summary. Participants in Group 1 will receive weekly emails and telephone calls and fortnightly sms reminder messages to continue with the program. Participants in group 2 will receive weekly emails and fortnightly sms reminder messages as well access to a clinician-moderated online forum discussing content of the program. The duration of each phone call is expected to be 2 minutes. The duration of the program is 8 weeks, but participants will be contacted 3 months post program and asked to complete follow-up questionnaires. Study questionnaires will be administered at application, pre-education, post-education, and at 3-months post-education. These will take about 20 minutes to complete. The educational materials are based on the Shyness Program, which applies cognitive behavioural techniques.
Intervention code [1] 4025 0
Other interventions
Comparator / control treatment
Internet based education for social phobia with automatic email and SMS reminders, and weekly telephone reminders.
Control group
Active

Outcomes
Primary outcome [1] 5407 0
Social phobia is measured by the Social Phobia Scale
Timepoint [1] 5407 0
Administered at pre-education, post-education, and at 3-months post-education.
Primary outcome [2] 5408 0
Social phobia is measured by the Social Interaction Anxiety Scale
Timepoint [2] 5408 0
Administered at pre-education, post-education, and at 3-months post-education.
Secondary outcome [1] 9090 0
Symptoms and severity of depression is measured by the Patient Health Questionnaire-9 (PHQ-9)
Timepoint [1] 9090 0
Administered at application, pre-education, post-education, and at 3-months post-education.
Secondary outcome [2] 9091 0
Psychological distress is measured by the Kessler-10 (K-10)
Timepoint [2] 9091 0
Administered at pre-education, post-education, and at 3-months post-education.
Secondary outcome [3] 9092 0
Disability is measured by the Sheehan Disability Scale
Timepoint [3] 9092 0
Administered at application, pre-education, post-education, and at 3-months post-education.

Eligibility
Key inclusion criteria
Meet DSM-IV criteria for social phobia - Internet access + printer access. - Australian citizen- Males and females.
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
Current substance abuse/dependence- Psychotic disorder- Current or planned psychological treatment during study duration- Change in medications during last 1 month or intended change during study duration.

Study design
Purpose of the study
Educational / counselling / training
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Participants apply on line, followed by a telephone interview to confirm diagnosis via structured diagnostic interview (MINI 5.0.0). Participants will be randomized using a list generated prior to the study. Allocation concealment will occur by contacting the holder of the allocation schedule who is off-site.
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
A randomisation list will be generated prior to the study using computer software
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?



Intervention assignment
Parallel
Other design features
Phase
Not Applicable
Type of endpoint/s
Efficacy
Statistical methods / analysis

Recruitment
Recruitment status
Completed
Date of first participant enrolment
Anticipated
16/03/2009
Actual
16/03/2009
Date of last participant enrolment
Anticipated
16/05/2009
Actual
16/05/2009
Date of last data collection
Anticipated
Actual
Sample size
Target
160
Accrual to date
Final
160
Recruitment in Australia
Recruitment state(s)

Funding & Sponsors
Funding source category [1] 4472 0
University
Name [1] 4472 0
School of Psychiatry, University of New South Wales at St Vincent's Hospital
Country [1] 4472 0
Australia
Primary sponsor type
University
Name
School of Psychiatry, University of New South Wales at St Vincent's Hospital
Address
299 Forbes Street Darlinghurst NSW2010
Country
Australia
Secondary sponsor category [1] 4031 0
None
Name [1] 4031 0
Address [1] 4031 0
Country [1] 4031 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 6534 0
University of New South Wales Human Research Ethics Committee
Ethics committee address [1] 6534 0
Ethics committee country [1] 6534 0
Australia
Date submitted for ethics approval [1] 6534 0
Approval date [1] 6534 0
01/09/2008
Ethics approval number [1] 6534 0
08230

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 29264 0
Prof Nick Titov
Address 29264 0
Department of Psychology
Macquarie University
NSW 2109
Country 29264 0
Australia
Phone 29264 0
61 2 9850 9901
Fax 29264 0
Email 29264 0
[email protected]
Contact person for public queries
Name 12511 0
Dr Nickolai Titov
Address 12511 0
C/- Clinical Research Unit for Anxiety Disorders (CRUfAD) UNSW 299 Forbes Street Darlinghurst NSW 2010
Country 12511 0
Australia
Phone 12511 0
+61 2 83821732
Fax 12511 0
Email 12511 0
[email protected]
Contact person for scientific queries
Name 3439 0
Dr Nickolai Titov
Address 3439 0
C/- Clinical Research Unit for Anxiety Disorders (CRUfAD) UNSW 299 Forbes Street Darlinghurst NSW 2010
Country 3439 0
Australia
Phone 3439 0
+61 2 83821732
Fax 3439 0
Email 3439 0
[email protected]

No information has been provided regarding IPD availability


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.